• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经 MitraClip® 装置治疗的被归类为不可手术的重度二尖瓣反流患者的住院治疗结果。

In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the MitraClip® device.

机构信息

University Medicine Rostock, Heart Center Rostock (Cardiology), Rostock, Germany.

出版信息

J Interv Cardiol. 2012 Apr;25(2):180-9. doi: 10.1111/j.1540-8183.2011.00688.x. Epub 2011 Dec 21.

DOI:10.1111/j.1540-8183.2011.00688.x
PMID:22188385
Abstract

BACKGROUND

To evaluate the short-term outcome of patients predominantly at high risk treated with the MitraClip® device for severe mitral valve regurgitation (MR) using one or more clips.

METHODS

We prospectively analyzed patients with highly symptomatic MR classified as inoperable (logistic EuroSCORE 24.16 ± 13.64%; STS-score 29.9 ± 14.5%) but subject to mitral valve repair with MitraClip® between May 2010 and January 2011. Thirty-three consecutive patients (57.6% male; age 77.8 ± 6.7 years) were enrolled and treated with either 1 (n = 7; 21.2%), 2 (n = 20; 60.6%), 3 (n = 4; 12.1%), or 4 (n = 2, 6.1%) clips. Grading of MR was performed by two-dimensional transesophageal echocardiography (2D-TEE) prior to TEE-guided clipping and before discharge.

RESULTS

MR was classified as functional in 23 (69.7%) and organic in 10 (30.3%) of the patients with MR-grade ≥ 3+ in 32 (97%) and = 4 in 1 patients (3%) before repair. Reduction in MR grade to grade ≤1+ was achieved in 81.7% and to 2 in 12.1% (P = 0.00072). Invasive pulmonary artery systolic pressure (PAPsyst) and pulmonary capillary wedge pressure (PCWP) v-wave decreased from 59.2 ± 18.6 to 46.9 ± 15.3 mmHg (P = 0.00014) and 21.2 ± 6.7 to 8.0 ± 3.3 mmHg (P = 0.0093), respectively, as measured immediately after clipping. Functional NYHA class improved from mean 3 (range 3 [90.9%] to 4 [9.1%]) to 2 in 84.9% (P = 0.00081) as obtained at discharge.

CONCLUSIONS

Mitral valve repair with MitraClip® using multiple clips is appropriate and safe in unselected patients resulting in reduced MR with positive impact on short-term functional capacity.

摘要

背景

本研究旨在评估使用 MitraClip®装置对高度危险的重度二尖瓣反流(MR)患者进行治疗的短期疗效,这些患者采用了 1 个或多个夹子。

方法

本研究前瞻性分析了 2010 年 5 月至 2011 年 1 月期间因高风险而接受 MitraClip®二尖瓣修复的高度症状性 MR 患者,这些患者被归类为手术禁忌(Logistic EuroSCORE 24.16±13.64%;STS 评分 29.9±14.5%)。33 例连续患者(57.6%为男性;年龄 77.8±6.7 岁)入选并接受治疗,采用 1 个(n=7;21.2%)、2 个(n=20;60.6%)、3 个(n=4;12.1%)或 4 个(n=2;6.1%)夹子。在 TEE 引导夹闭和出院前,通过二维经食管超声心动图(2D-TEE)对 MR 进行分级。

结果

MR 分级≥3+的患者中,23 例(69.7%)为功能性,10 例(30.3%)为器质性,修复前 MR 分级为 4 级的患者有 1 例(3%),2 级的患者有 32 例(97%)。81.7%的患者 MR 分级降至≤1+,12.1%的患者降至 2 级(P=0.00072)。夹闭后即刻,经测量,肺动脉收缩压(PAPsyst)和肺毛细血管楔压(PCWP)v 波分别从 59.2±18.6mmHg 降至 46.9±15.3mmHg(P=0.00014)和从 21.2±6.7mmHg 降至 8.0±3.3mmHg(P=0.0093)。夹闭后即刻,84.9%(31/37)的患者纽约心脏协会(NYHA)心功能分级从平均 3 级(范围 3 级[90.9%]至 4 级[9.1%])改善至 2 级(P=0.00081)。

结论

在未经选择的患者中,使用多个夹子进行二尖瓣修复是安全且合适的,可减少 MR,对短期心功能有积极影响。

相似文献

1
In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the MitraClip® device.经 MitraClip® 装置治疗的被归类为不可手术的重度二尖瓣反流患者的住院治疗结果。
J Interv Cardiol. 2012 Apr;25(2):180-9. doi: 10.1111/j.1540-8183.2011.00688.x. Epub 2011 Dec 21.
2
Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study.基于导管的二尖瓣瓣叶修复的急性和 12 个月结果:EVEREST II(血管内瓣缘对瓣缘修复)高危研究。
J Am Coll Cardiol. 2012 Jan 10;59(2):130-9. doi: 10.1016/j.jacc.2011.08.067.
3
Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes.经皮二尖瓣修复术后急性血液动力学变化与中期结果的关系。
Heart. 2012 Jan;98(2):126-32. doi: 10.1136/heartjnl-2011-300705. Epub 2011 Oct 7.
4
Concept of the central clip: when to use one or two MitraClips®.中央夹的概念:何时使用一个或两个 MitraClip®。
EuroIntervention. 2014 Feb;9(10):1217-24. doi: 10.4244/EIJV9I10A204.
5
Initial French experience of percutaneous mitral valve repair with the MitraClip: a multicentre national registry.法国经皮二尖瓣修复术的初步经验:多中心全国注册研究。
Arch Cardiovasc Dis. 2013 May;106(5):287-94. doi: 10.1016/j.acvd.2013.03.059. Epub 2013 May 28.
6
Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes.外科或经皮二尖瓣修复术治疗继发性二尖瓣反流:患者特征和临床结局比较。
Eur J Cardiothorac Surg. 2013 Sep;44(3):490-6; discussion 496. doi: 10.1093/ejcts/ezt036. Epub 2013 Feb 10.
7
Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: a single-centre experience.经皮二尖瓣修复术联合 MitraClip 系统治疗轻中度和重度心力衰竭患者:单中心经验。
Cardiovasc Ther. 2014 Apr;32(2):66-73. doi: 10.1111/1755-5922.12058.
8
Should a mild to moderate ischemic mitral valve regurgitation in patients with poor left ventricular function be repaired or not?左心室功能不佳的患者中,轻度至中度缺血性二尖瓣反流是否应进行修复?
J Heart Valve Dis. 1995 Sep;4(5):484-8; discussion 488-9.
9
Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.使用MitraClip系统进行经皮二尖瓣修复术:在最初的EVEREST(血管内瓣膜边缘对边缘修复研究)队列中的安全性和中期耐久性。
J Am Coll Cardiol. 2009 Aug 18;54(8):686-94. doi: 10.1016/j.jacc.2009.03.077.
10
Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients.经皮二尖瓣修复术(MitraClip)学习曲线对治疗效果的影响及前 75 例连续患者的经验教训。
Eur J Heart Fail. 2011 Dec;13(12):1331-9. doi: 10.1093/eurjhf/hfr141. Epub 2011 Oct 24.

引用本文的文献

1
Daily non-invasive haemodynamic telemonitoring for efficacy evaluation of MitraClip® implantation in patients with advanced systolic heart failure.每日非侵入性血流动力学远程监测评估晚期收缩性心力衰竭患者 MitraClip®植入术的疗效。
ESC Heart Fail. 2018 Oct;5(5):780-787. doi: 10.1002/ehf2.12303. Epub 2018 Jun 12.
2
Percutaneous edge-to-edge mitral valve repair. Current clinical evidence with the MitraClip System.
Herz. 2013 Aug;38(5):448-52. doi: 10.1007/s00059-013-3868-1.
3
Mitral valve with three orifices after percutaneous repair with the MitraClip system: the triple-orifice technique.
Clin Res Cardiol. 2012 Oct;101(10):847-9. doi: 10.1007/s00392-012-0451-3. Epub 2012 Mar 31.